Frontlight ResearchEarly access
CompletedNo phase
PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL
Key facts
- Who runs it
- Beaver-Visitec International, Inc.
- Where
- Austria, Czechia, Germany, Ireland, Philippines, and Spain12 sites in 6 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 250 people enrolled
- Started
- 11 Feb 2020
- Ended
- 18 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- IOL implantation experimental (Isopure 1.2.3.)
- IOL implantation active comparator (Micropure 1.2.3.)
- Record updated
- 21 November 2025
Who can take part
- Age
- 45 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Cataractous eyes with no comorbidity
- Calculated IOL power is within the range of the study IOLs
- Male or female adults ages 45 years or older on the day of screening who have cataract(s) in one or both eyes
- Regular corneal astigmatism ≤1.0 D (measured by an automatic keratometer)
- Clear intraocular media other than cataract
- Availability, willingness and sufficient cognitive awareness to comply with examination procedures
- Signed informed consent
Who cannot take part
- Previous intraocular or corneal surgery
- Expected complicated surgery
- Difficulty for cooperation (distance from their home, general health conditions)
- Subjects with diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal or optic disorders) that are predicted to cause future acuity losses to a level of 20/30 or worse
- Ocular hypertension or glaucoma
- Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic / scotopic conditions)
- Age of patient < 45 years
- Regular corneal astigmatism >1.0 dioptres (measured by an automatic keratometer)
- Irregular astigmatism
- Subjects with AMD suspicious eyes as determined by OCT examination
- Subjects who may be expected to require retinal laser treatment during the course of the study or at a greater risk of developing cystoid macular edema
- Traumatic cataract
- History or presence of macular edema
- Instability of keratometry or biometry measurements
- Significant dry eye
Where is this trial?
It has sites in 6 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Multicenter, prospective, randomised, controlled, single-blind post-market clinical follow-up (PMCF) study to compare the clinical outcomes of an enhanced depth of focus (EDOF) IOL with the outcomes obtained with a monofocal lens. Implantation of the IOLs is bilaterally.
The 2 groups in the trial
- IOL implantation experimentalTreatment being tested
Experimental arm: Enhanced depth of focus (EDOF) intraocular lens.
Treatment: IOL implantation experimental (Isopure 1.2.3.)
- IOL implantation active comparatorExisting treatment, for comparison
Comparator arm: Monofocal intraocular lens.
Treatment: IOL implantation active comparator (Micropure 1.2.3.)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multicentric Post-Market Clinical Follow-up (PMCF) Investigation to Determine Safety and Efficacy of a Hydrophobic EDOF Intraocular Lens (IOL) in Comparison to a Monofocal IOL
- Record updated
- 21 November 2025